Inhibition of HIV-1 Replication by Hydroxychloroquine: Mechanism of Action and Comparison with Zidovudine

Clinical Therapeutics

Volumn 18, Issue 6, 1996, Pages 1080-1092

  Chiang, Grace ^a   Sassaroli, Massimo ^a   Louie, Michael ^a   Chen, Houchu ^a   Stecher, Vera J ^b   Sperber, Kirk ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Sanofi Winthrop Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT; GLYCOPROTEIN GP 120; HYDROXYCHLOROQUINE; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ARTICLE; CELL PH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENANTIOMER; ENDOSOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; RHEUMATIC DISEASE; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIMALARIALS; CELL DIVISION; CELL LINE; ENDOSOMES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXYCHLOROQUINE; LYSOSOMES; MACROPHAGES; MONOCYTES; PRECIPITIN TESTS; RNA, VIRAL; T-LYMPHOCYTES; VIRUS REPLICATION; ZIDOVUDINE;

EID: 0030483522     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80063-4     Document Type: Article

References (27)

1. Hirsch MS, D'Aquila RT. Therapy for human immunodeficiency virus infection. NEJM. 1993;328:1686-1695.
2. Sperber K, Kalb TH, Stecher V, et al. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses. 1993;9:91-98.
3. Sperber K, Louie MJ, Kraus T, et al. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther. 1995;17:622-636.
4. Ornstein M, Sperber K. The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum. 1996;39:157-161.
5. Mellman I, Fuchs R, Helerius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 1986;55: 663-700.
6. Oda K, Koriyama Y, Yomada E, Ikahara Y. Effects of weakly basic amines on proteolytic processing and terminal glycosylation of secretory proteins in cultured rat hepatocytes. Biochem J. 1986;240:739-745.
7. Oda K, Ikahara Y. Weakly basic amines inhibit the proteolytic conversion of proalbumin to albumin in cultured rat hepatocytes. Eur J Biochem. 1985;52:605-609.
8. Mackenzie AH, Scherbel AL. Chloroquine and hydroxychloroquine in rheumatological therapy. Clin Rheum Dis. 1980;6: 545-566.
9. Tett SE, Day RO, Cutler DJ. Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis - a cross sectional study. J Rheumatol. 1993;20: 1874-1879.
10. Panayi GS, Neill WA, Duthrie JJR, McCormick JN. Action of chloroquine phosphate in rheumatoid arthritis. Immunosuppressive effects. Ann Rheum Dis. 1973; 32:316-322.
11. Wainer IW, Chen JC, Parenteau H, et al. Distribution of the enantiomers of hydroxychloroquine and its metabolites in ocular tissues of the rabbit after oral administration of racemic-hydroxychloroquine. Chirality. 1994;6:347-354.
12. Sperber K, Hamrung G, Louie MJ, et al. Progressive impairment of monocytic function in HIV-1 infected human macrophage hybridomas. AIDS Res Hum Retroviruses. 1993;9:657-667.
13. Banerjee R, Bekesi J, Tarcsafalvi A, et al. Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proc Natl Acad Sci USA. 1992;89:9996-10000.
14. Sperber K, Bauer J, Pizzimenti A, et al. Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas. J Immunol Methods. 1990;129:31-40.
15. Ohkuma S, Poole B. Fluorescence probe measurements in the intralysosomal pH in living cells and perturbation of pH by various agents. Proc Natl Acad Sci USA. 1978;75:3327-3331.
16. Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol. 1981;90: 665-669.
17. Geisow MJ, D'arcy Hart P, Young MR. Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages: Studies by fluorescence spectroscopy. J Cell Biol. 1981;89: 645-652.
18. Maxfield FR. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol. 1982;95:676-681.
19. Ohkuma S. Use of fluorescein isothiocyanate-dextran to measure proton pumping in lysosomes and related organelles. Methods Enzymol. 1989;174:131-154.
20. Zdolsek JM, Svensson I. Effect of reactive oxygen species on lysosomal membrane integrity. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64:401-406.
21. Hoffman AD, Banapour B, Levey JA. Characteristics of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 1985;147:326-335.
22. Sperber K, Shaked A, Posnett DN, et al. Surface expression of CD-4 does not predict susceptibility to infection with HIV-1 in human monocyte hybridomas. J Clin Lab Immunol. 1990;31:151-156.
23. Pinter A, Honnen WJ, Racho ME, Tilley SA. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates. AIDS Res Hum Retroviruses. 1993; 9:985-996.
24. Tsai WP, Nara PL, Kung HF, Oroszlan S. Inhibition of human immunodeficiency virus by chloroquine. AIDS Res Hum Retroviruses. 1990;6:481-489.
25. Pal R, Gallo RC, Sarnagadharan MG. Processing of the structural proteins of human immunodeficiency virus type 1 in the processing of monesin and cerulenin. Proc Natl Acad Sci USA. 1989;85:9283-9286.
26. Rynes RI, Krobel G, Falbot A, et al. Ophthalmologic safety of long-term hydroxychloroquine therapy. Arthritis Rheum. 1979;22:833-836.
27. Poli G, Kiner A, Folks TM, Fauci AS. Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989;244:575-577.